Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

More On LOR.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Lorus Therapeutics Inc (LOR.TO)

-Toronto
0.50 Down 0.02(3.85%) Sep 2, 3:53PM EDT
Add to Portfolio
Prev Close:0.52
Open:0.52
Bid:0.49
Ask:0.50
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.49 - 0.52
52wk Range:0.18 - 1.04
Volume:213,228
Avg Vol (3m):N/A
Market Cap:5.94M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.29
Quarterly EPS Est (Jun-15) :-0.33
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback